WallStreetZenWallStreetZen

AnalystsChris Howerton
Chris Howerton's Stock Forecasts

Analyst Ranking
Top 10%
#448 out of 4602 analysts
Average Return
+18.74%
Win Rate
47%28 out of 60
Risk vs Reward
Poor
Good

Chris Howerton's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Provention Bio IncPRVB
+413.28%$4.67$23.97
2022-09-19 -
2023-03-14
Strong Buy
Celldex Therapeutics IncCLDX
+303.93%$84.00$339.30
2012-10-31 -
2013-11-01
Strong Buy
Celldex Therapeutics IncCLDX
+280.86%$89.09$339.30
2012-11-01 -
2013-11-01
Strong Buy
Provention Bio IncPRVB
+246.39%$6.92$23.97
2022-10-06 -
2023-03-14
Strong Buy
Ardelyx IncARDX
+243.53%$0.85$2.92
2022-03-01 -
2023-03-01
Strong Buy

Chris Howerton's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Structure Therapeutics IncGPCR
2Strong Buy$79.00+52.98%Maintains
9 months ago
Point Biopharma Global IncPNT
2Strong Buy$14.00+12.00%Assumes
a year ago
Milestone Pharmaceuticals IncMIST
3Hold$4.00+179.72%Downgrades
a year ago
Veru IncVERU
3Hold$1.00N/AUpgrades
a year ago
Provention Bio IncPRVB
4Hold$25.00N/ADowngrades
a year ago
Bioxcel Therapeutics IncBTAI
2Hold$22.00N/ADowngrades
a year ago
Applied Molecular Transport IncAMTI
3Sell$0.40N/ADowngrades
a year ago
Avalo Therapeutics IncAVTX
3Sell$720.00N/ADowngrades
a year ago
Compugen LtdCGEN
2Sell$0.50N/ADowngrades
a year ago
Urogen Pharma LtdURGN
1Hold$10.00N/ADowngrades
a year ago
Mei Pharma IncMEIP
3Sell$2.00N/ADowngrades
a year ago
Landos Biopharma IncLABP
3Sell$1.00N/ADowngrades
a year ago
Vectivbio Holding AgVECT
1Strong Buy$18.00N/AInitiates Coverage On
2 years ago
Avadel Pharmaceuticals PLCAVDL
3Strong Buy$11.00N/AUpgrades
2 years ago
Iveric Bio IncISEE
2Hold$20.00N/ADowngrades
2 years ago
Apellis Pharmaceuticals IncAPLS
2Hold$40.00N/ADowngrades
2 years ago
Harmony Biosciences Holdings IncHRMY
3Strong Buy$61.00N/AUpgrades
2 years ago
Axsome Therapeutics IncAXSM
3Strong Buy$90.00N/AMaintains
2 years ago
Finch Therapeutics Group IncFNCH
2Strong Buy$510.00N/AMaintains
2 years ago
Karuna Therapeutics IncKRTX
1Strong Buy$183.00N/AMaintains
2 years ago
Ardelyx IncARDX
3Strong Buy$5.00N/AUpgrades
2 years ago
Disc Medicine IncIRON
2Hold$1.50N/ADowngrades
2 years ago
Vanda Pharmaceuticals IncVNDA
1Hold$12.00N/ADowngrades
2 years ago
Arena Pharmaceuticals IncARNA
1Hold$100.00N/ADowngrades
3 years ago
Igm Biosciences IncIGMS
1Strong Buy$126.00N/AMaintains
3 years ago
Io Biotech IncIOBT
1Strong Buy$20.00N/AInitiates Coverage On
3 years ago
Celldex Therapeutics IncCLDX
9Strong Buy$66.00N/AInitiates Coverage On
3 years ago
Omega Therapeutics IncOMGA
1Strong Buy$30.00N/AInitiates Coverage On
3 years ago
Candel Therapeutics IncCADL
1Strong Buy$22.00N/AInitiates Coverage On
3 years ago
Tscan Therapeutics IncTCRX
1Strong Buy$21.00N/AInitiates Coverage On
3 years ago
Werewolf Therapeutics IncHOWL
1Strong Buy$22.00N/AInitiates Coverage On
3 years ago
Lava Therapeutics NvLVTX
1Strong Buy$23.00N/AInitiates Coverage On
3 years ago
Evelo Biosciences IncEVLO
3Strong Buy$360.00N/AUpgrades
3 years ago
Acadia Pharmaceuticals IncACAD
2Hold$21.00N/ADowngrades
3 years ago
Alaunos Therapeutics IncTCRT
1Hold$5.00N/ADowngrades
3 years ago
Pluri IncPLUR
2Hold$6.00N/ADowngrades
4 years ago
Immunomedics IncIMMU
1Hold$88.00N/ADowngrades
4 years ago
Chiasma IncCHMA
1Strong Buy$8.00N/AInitiates Coverage On
4 years ago
Seres Therapeutics IncMCRB
1Strong Buy$29.00N/AUpgrades
4 years ago
Bellerophon Therapeutics IncBLPH
1Strong Buy$19.00N/AInitiates Coverage On
4 years ago
Therapeuticsmd IncTXMD
1Sell$60.00N/ADowngrades
4 years ago
Corcept Therapeutics IncCORT
1Hold$16.00N/ADowngrades
4 years ago
Protagonist Therapeutics IncPTGX
1Strong Buy$27.00N/AInitiates Coverage On
4 years ago
Lyra Therapeutics IncLYRA
1Strong Buy$24.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.